Mesa Laboratories, Inc. (MLAB) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund lessened its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 0.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,400 shares of the medical instruments supplier’s stock after selling 1 shares during the quarter. New York State Common Retirement Fund owned approximately 0.09% of Mesa Laboratories worth $487,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. PNC Financial Services Group Inc. grew its stake in Mesa Laboratories by 2.3% during the 2nd quarter. PNC Financial Services Group Inc. now owns 3,117 shares of the medical instruments supplier’s stock valued at $446,000 after acquiring an additional 71 shares in the last quarter. BT Investment Management Ltd purchased a new position in Mesa Laboratories during the 2nd quarter valued at about $277,000. King Luther Capital Management Corp grew its stake in Mesa Laboratories by 24.4% during the 2nd quarter. King Luther Capital Management Corp now owns 30,491 shares of the medical instruments supplier’s stock valued at $4,370,000 after acquiring an additional 5,980 shares in the last quarter. TIAA CREF Investment Management LLC grew its stake in Mesa Laboratories by 10.9% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 8,552 shares of the medical instruments supplier’s stock valued at $1,226,000 after acquiring an additional 841 shares in the last quarter. Finally, Teachers Advisors LLC lifted its holdings in shares of Mesa Laboratories by 14.9% during the 2nd quarter. Teachers Advisors LLC now owns 5,660 shares of the medical instruments supplier’s stock valued at $811,000 after buying an additional 733 shares during the last quarter. 68.83% of the stock is currently owned by institutional investors.

Shares of Mesa Laboratories, Inc. (MLAB) opened at $127.04 on Tuesday. The stock has a market capitalization of $479.58, a PE ratio of 33.57 and a beta of 0.49. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.97 and a current ratio of 2.86. Mesa Laboratories, Inc. has a 1-year low of $109.14 and a 1-year high of $169.80.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings results on Monday, November 6th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.64 by ($0.04). The firm had revenue of $22.95 million for the quarter, compared to analyst estimates of $25.50 million. Mesa Laboratories had a net margin of 11.48% and a return on equity of 14.77%. sell-side analysts anticipate that Mesa Laboratories, Inc. will post 2.47 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Thursday, November 30th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Wednesday, November 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.50%. Mesa Laboratories’s dividend payout ratio is 23.10%.

Several equities research analysts have recently issued reports on the company. TheStreet upgraded Mesa Laboratories from a “c+” rating to a “b” rating in a report on Monday, November 6th. BidaskClub lowered Mesa Laboratories from a “sell” rating to a “strong sell” rating in a report on Saturday, August 12th. Finally, Zacks Investment Research lowered Mesa Laboratories from a “buy” rating to a “strong sell” rating in a report on Friday.

In related news, Director H Stuart Campbell sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $130.16, for a total value of $130,160.00. Following the completion of the sale, the director now directly owns 42,366 shares in the company, valued at approximately $5,514,358.56. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 15.70% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Mesa Laboratories, Inc. (MLAB) Shares Sold by New York State Common Retirement Fund” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.chaffeybreeze.com/2017/11/14/mesa-laboratories-inc-mlab-shares-sold-by-new-york-state-common-retirement-fund.html.

Mesa Laboratories Profile

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB).

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply